Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: Insights on the origin of the "kaposi's sarcoma belt"

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2395-2401

  Dollard, Sheila C ^a   Butler, Lisa M ^b   Jones, Alison M Graves ^b   Mermin, Jonathan H ^c   Chidzonga, Midion ^d   Chipato, Tsungai ^d   Shiboski, Caroline H ^e   Brander, Christian ^f,g   Mosam, Anisa ^h,i   Kiepiela, Photini ^j   Hladik, Wolfgang ^a   Martin, Jeffrey N ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ UNIVERSITY OF KWAZULU NATAL   (South Africa)

^j SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

more..

Author keywords

adults; Africa; HHV 8; KSHV

Indexed keywords

HUMAN HERPESVIRUS 8 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ADULTHOOD; ANTIBODY DETECTION; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; SOUTH AFRICA; UGANDA; ZIMBABWE; AFRICA SOUTH OF THE SAHARA; CHILD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HERPES VIRUS INFECTION; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 78049506555     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25235     Document Type: Article

References (43)

1. Cook-Mozaffari P, Newton R, Beral V, Burkitt DP,. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78: 1521-8.
2. Ziegler JL,. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993; 342: 1348-51.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS,. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
4. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, Miller RF, Weller IVD,. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799-802.
5. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore PS,. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-41.
6. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH,. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948-54.
7. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J,. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998; 12: 2481-8.
8. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ,. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999; 180: 1010-7.
9. Martin JN, Ganem DE, Osmond DH, Page-Shafer K, Macrae D, Kedes DH,. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948-54.
10. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D,. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918-24.
11. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ,. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196: 199-207.
12. Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, Coutinho RA, Goudsmit J,. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000; 151: 213-24.
13. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P,. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998; 36: 1784-6.
14. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF,. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77: 543-8.
15. Beral V, Peterman TA, Berkelman RL, Jaffe HW,. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-8.
16. Sissolak G, Mayaud P,. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health 2005; 10: 981-92.
17. Ablashi DV, Chatlynne LG, Whitman JE, Jr, Cesarman E,. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 2002; 15: 439-64.
18. Dedicoat M, Newton R,. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003; 88: 1-3.
19. Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Soderstrom T, Wadstrom J, et al. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol 2000; 62: 498-504.
20. Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM,. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355: 1331-8.
21. Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA,. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998; 36: 1574-7.
22. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE,. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000; 38: 2174-80.
23. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ,. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45: 500-3.
24. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003; 43: 1260-8.
25. Cannon MJ, Operskalski EA, Mosley JW, Radford K, Dollard SC,. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis 2009; 199: 1592-8.
26. Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF,. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004; 190: 1068-75.
27. Bourboulia D, Whitby D, Boshoff C, Newton R, Beral V, Carrara H, Lane A, Sitas F,. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA 1998; 280: 31-2.
28. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, et al. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer 2003; 103: 226-32.
29. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ,. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003; 187: 1780-5.
30. Eltom MA, Mbulaiteye SM, Dada AJ, Whitby D, Biggar RJ,. Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. AIDS 2002; 16: 2473-8.
31. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL,. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta. Int J Cancer 2000; 88: 1003-8.
32. Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard SC, et al. Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis 2009; 200: 430-8.
33. Baeten JM, Chohan BH, Lavreys L, Rakwar JP, Ashley R, Richardson BA, Mandaliya K, Bwayo JJ, Kreiss JK,. Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya. AIDS 2002; 16: 2073-8.
34. Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M,. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12: 1921-5.
35. Avelleira JC, Lupi O, Caterino-de-Araujo A, Santos-Fortuna Ede L,. Seroprevalence of HHV-8 infection in the pediatric population of two university hospitals in Rio de Janeiro, Brazil. Int J Dermatol 2006; 45: 381-3.
36. Malope BI, Pfeiffer RM, Mbisa G, Stein L, Ratshikhopha EM, O'Connell DL, Sitas F, MacPhail P, Whitby D,. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 2007; 44: 351-5.
37. Minhas V, Crabtree KL, Chao A, M'soka TJ, Kankasa C, Bulterys M, Mitchell CD, Wood C,. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol 2008; 168: 311-20.
38. Brayfield BP, Phiri S, Kankasa C, Muyanga J, Mantina H, Kwenda G, West JT, Bhat G, Marx DB, Klaskala W, Mitchell CD, Wood C,. Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J Infect Dis 2003; 187: 559-68.
39. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM, Mermin J, Lackritz EM,. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 2003; 33: 206-10.
40. Enbom M, Tolfvenstam T, Ghebrekidan H, Ruden U, Grandien M, Wahren B, Linde A,. Seroprevalence of human herpes virus 8 in different Eritrean population groups. J Clin Virol 1999; 14: 167-72.
41. Lyall EG, Patton GS, Sheldon J, Stainsby C, Mullen J, O'shea S, Smith NA, De Ruiter A, McClure MO, Schulz TF,. Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers, Pediatr. Infect Dis J 1999; 18: 795-9.
42. Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C,. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 2005; 75: 93-100.
43. Lavreys L, Chohan B, Ashley R, Richardson BA, Corey L, Mandaliya K, Ndinya-Achola JO, Kreiss JK,. Human herpesvirus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya. J Infect Dis 2003; 187: 359-63.